ライフサイエンスコーパス: weight

1 weight loss of 10.5 kg (10% of initial body weight).

2 atients primarily admitted for EH (n = 4,655 weighted).

3 ate PI3Kalpha inhibitor with a low molecular weight.

4 creening children and adolescents for excess weight.

5 4% to 7%, and starch from 4% to 10% per dry weight.

6 on-based rates were estimated using sampling weights.

7 ing, and by inverse probability-of-treatment weighting.

8 in adolescents (per 100-g increase in birth weight, -0.004 grade, 95% CI: -0.04, 0.04) using instrum

9 of kidney, spleen and liver weights to body weight, 36 of which were imprinted with different imprin

10 panic, 81.6%; mean weight above prepregnancy weight, 7.8 kg; mean months post partum, 5.2 months) ran

11 (mean age, 28.1 years; Hispanic, 81.6%; mean weight above prepregnancy weight, 7.8 kg; mean months po

12 ntestinal failure, increasing intestinal wet weight absorption and reducing diarrhea.

13 virus remained the leading etiology (overall weighted AF, 40.3% [95% confidence interval {CI}, 37.6%-

14 ed by 3416 individuals in NHANES, the median weighted age was 53 years (interquartile range, 46-61),

15 icrom) sirolimus-eluting ultrahigh molecular weight amorphous poly-l-lactic acid-based BRS (APTITUDE,

16 Raw and inverse probability of treatment-weighted analyses were performed to compare patients und

17 ta identify GFRAL as a new regulator of body weight and as the bona fide receptor mediating the metab

18 Secondary end points included change in body weight and cardiometabolic parameters.

19 Gestational hypoxia caused low birth-weight and changes in young adult offspring brain, mimic

20 show that the association between low birth weight and decreased cognitive ability has declined betw

21 Gpr119(-/-) mice displayed normal body weight and glucose tolerance on a regular chow (RC) diet

22 httime noise and robust to different spatial weight and neighbor definitions.

23 e (SD) in cognitive scores between low-birth-weight and normal-birth-weight children was large in the

24 Total fresh weight and number of leaves were higher at 4th growth st

25 m cells (uMSC) from offspring born to normal-weight and obese mothers, we tested the hypothesis that

26 ted versus did not complete a daily diary of weight and symptom self-assessment and to identify predi

27 istently elevate ingestive behavior and body weight and ultimately resulted in a doubling of fat mass

28 ng protocol consisting of only transverse T2-weighted and diffusion-weighted imaging pulse sequences

29 Magnetic resonance (MR) imaging (T1-weighted and diffusion-weighted imaging) was performed w

30 resonance (MR) imaging modalities such as T1-weighted and diffusion-weighted MR imaging could reveal

31 ssionals leads to a greater effect on HbA1c, weight, and LDL cholesterol.

32 hyl- and ethyl- functional groups, molecular weight, and number of ring structures, in addition to th

33 composition was associated with caterpillar weight, and thus, our results provide no support for the

34 ese limitations, but the current size, bulk, weight, and wireless area of coverage is often disadvant

35 Sample weighting approaches had little impact on field-estimate

36 ent years, remaining errors in the Boltzmann weights are still on the order of a few [Formula: see te

37 IV-exposed newborns had a similar length and weight as newborns without HIV exposure, but their head

38 r maternal age, ethnicity, birth country and weight, as well as infant gender, birth year and birth m

39 likelihood ratio test, c index, and clinical weight at each step.

40 re used to account for nonlinearity.Maternal weight at each time point had a consistent nonlinear rel

41 ogeny for variable infection times by a time-weighted average of probabilities for simultaneous infec

42 tion of the binding affinity by isotherms of weight-average sedimentation coefficients sw.

43 te the known toxicity of some high-molecular-weight azaarenes, their diversity, abundance, and fate i

44 despite a higher proportion of the low-birth-weight babies having a very low birth weight (<1,500 g)

45 nt variables were 8.20-59.17mg/100g on fresh weight basis.

46 American breast cancer survivors (AABCS) on weight, body composition, and behavior.

47 sible associations of age, body length, body weight, body surface area, and heart rate on PAAT were i

48 They achieved normal weight by 12 months, a significant improvement over a pr

49 r diseases and iron overload was calculated (weighted by probability of participation).

50 The primary outcome was weight change over 12 months, based on measurements at b

51 a-analysis of experimental studies (SSBs and weight change), a meta-analysis of prospective cohort st

52 tor have yielded somewhat disappointing body weight changes, often leading to the hormone/mediator in

53 In low-birth-weight children (<2500 g), the RNFL was 3.5 mum (95% CI,

54 3 mum; P = .02) thinner than in normal-birth-weight children after adjustment for all variables.

55 es between low-birth-weight and normal-birth-weight children was large in the NCDS [-0.37 SD, 95% con

56 ese children with asthma with that in normal-weight children with asthma to identify key differential

57 e nucleotide polymorphisms determining birth weight combined with results from the Social Science Gen

58 e structural complexity and heterogeneity of weighted complex networks.

59 ed to determine changes in the low-molecular-weight compound composition of peanuts due to dry-roasti

60 tance, ranging from a decrease in population-weighted concentrations when UV reflectance remains unch

61 nce of systemic inhibition of DGAT1 for body weight control.

62 Hazard ratios were estimated with weighted Cox regression models using Barlow weights to a

63 pore diameter of 1.0-1.3 nm with a molecular weight cutoff (MWCO) of 1000-2000 Da but also have a hig

64 membranes of various material and molecular-weight cutoff values.

65 e comprised 670 women in a trial with serial weight data (7310 observations) that were available befo

66 In model neurons, such changes of the weight dependence of heterosynaptic plasticity shifted t

67 Grain weight, determined by grain length and width, is an impo

68 ic differences in muscle metabolism and body weight development.

69 31 (93.9%) of 33 in the dolutegravir group (weighted difference 2.9%, 95% CI -8.5 to 14.2; p=0.50).

70 forms of PE, displaying different molecular weight distributions and oxidation levels, lead to an in

71 By modeling the molecular weight distributions obtained under various reaction con

72 in IX significantly reduces the loss of body weight due to hRSV-induced disease.

73 entrations ranging from 542 to 3645 ng/g dry weight (dw).

74 geneous tumour, we evaluate its fitness as a weighted effect of dominant neoantigens in the subclones

75 sent fetal growth charts for estimated fetal weight (EFW) and common ultrasound biometric measurement

76 from microspheres made of a higher molecular weight, ester end-capped PLGA displayed an osmotically i

77 lar lung water was indexed to predicted body weight (EVLWPBW).

78 Conclusion Dixon T2-weighted fat-only and water-only imaging provide, in one

79 associated with preterm delivery, low birth weight, fetal growth retardation and developmental defec

80 the results suggest an MS level relative to weight for having a low metabolic risk, which could be u

81 ivo, and patient features and their relative weights for predicting 36-mo survival.

82 acebo group was similar (mean [SD] change in weight-for-age z score: +0.14 [0.83] and +0.18 [0.85], r

83 s in all postnatal growth parameters (except weight-for-length), accompanied by declines over time in

84 This suggests that the smallest molecular weight fraction is more susceptible to processes that le

85 s 0.57+/-0.39mg cyanidin-3-glucoside/g fresh weight (FW) and TPC was 6.07+/-2.17mg gallic acid equiva

86 on, all culminating in significantly reduced weight gain and adiposity.

87 Animals in group 1 continued to have weight gain and biochemical analyses comparable to wild-

88 Attention to symptoms of weight gain and dyspnea are central tenets of patient ed

89 nce might be early events that contribute to weight gain and obesity development.

90 Despite enhanced weight gain and plasma lipid levels compared with Apoe(-

91 cs such as olanzapine often induce excessive weight gain and type 2 diabetes.

92 We assessed weight gain from birth until 6 mo.

93 Weight gain in the trimethoprim-sulfamethoxazole group a

94 as found to be effective in suppressing body weight gain relative to control in a diet-induced obese

95 While hyperleptinemia and pre-pregnancy weight gain were present in all db/+mice across the four

96 n of Cadm1 in excitatory neurons facilitated weight gain while exacerbating energy expenditure.

97 yl cytidine (AraC) blunted food intake, body weight gain, and adiposity.

98 ut not parental age nor maternal gestational weight gain, were associated with NAFLD in male offsprin

99 associated with increased caloric intake and weight gain.

100 nization in the small intestine and impaired weight gain.

101 riatal networks relevant to food craving and weight gain.

102 ne module most highly associated for COPD in Weighted Gene Co-Expression Network Analysis (WGCNA) was

103 gene expression patterns in combination with weighted gene coexpression networks and generalized addi

104 A weighted genetic risk score was calculated by the natura

105 mation including linkage disequilibrium (LD)-weighted genic annotation scores, total LD scores and he

106 In the subgroup of patients who lost weight, glycemia, homeostasis model of assessment of ins

107 Weighted graph networks were then converted to circuits,

108 We propose a novel differentially weighted graphical LASSO (dwgLASSO) algorithm that build

109 In this paper, we apply weighted graphical LASSO (wgLASSO) algorithm to integrat

110 ernal smoking during pregnancy and low birth weight have been implicated in impaired development of t

111 smoked after correction for age, sex, birth weight, height, body weight, Tanner stage of pubertal de

112 We hypothesized that low molecular weight heparin (LMWH) is superior to unfractionated hepa

113 overed and characterized from high-molecular weight (HMW) fractions of an IgG1 monoclonal antibody (m

114 o three groups based on stimulation and body weight (i.e., lean nonstimulated, obese nonstimulated, a

115 Resting-state (rs)-fMRI and diffusion weighted imaging (DWI) scans were undertaken before unil

116 rmine the usefulness of whole-body diffusion-weighted imaging (DWI) to assess the response of bone me

117 Diffusion-weighted imaging data of 12 treatment-naive patients wit

118 of only transverse T2-weighted and diffusion-weighted imaging pulse sequences compared with that of a

119 ance (MR) imaging (T1-weighted and diffusion-weighted imaging) was performed with a 3-T MR imager.

120 g (T2-weighted turbo spin-echo and diffusion-weighted imaging), acquired within 8 minutes 45 seconds

121 of >33) demonstrated good agreement with T2-weighted imaging-derived AAR (bias, 0.18; 95% confidence

122 by selectively slowing down learning on the weights important for those tasks.

123 their initial body mass index (calculated as weight in kilograms divided by height in meters squared)

124 y was defined as a body-mass index (BMI, the weight in kilograms divided by the square of the height

125 clinically used GLP-1 analog, to reduce body weight in rats, suggesting that serotonin is a critical

126 rgans are significantly associated with body weight in terms of phenotypic relative growth.

127 in nutritional status, with normalization of weight in the first year of life.

128 e adjusted mean change from baseline in body weight in the surgery group was -45.0 kg (95% confidence

129 zation operator which acts as a time-varying weighting in the morphological reconstruction.

130 associated with preterm birth and low birth weight included treatment with chemotherapy and a diagno

131 Weight increased by 0.68 and 1.75 kg in the IN and RE gr

132 Cronbach alpha values for mean weighted internal consistency were 0.83 and 0.89 for the

133 /S transition (Rb-positive and low-molecular-weight isoform of cyclin E (cytoplasmic)-negative) is a

134 0.68 (77 of 113; 95% CI: 0.59, 0.76), with a weighted kappa of 0.59 (95% CI: 0.47, 0.71).

135 of breast cancer with body mass index (BMI; weight (kg)/height (m)2) at age 18-21 years, BMI at base

136 for height, weight, or body mass index (BMI; weight (kg)/height (m)2) measured concurrently with the

137 /fl) ) mice both responded with reduced body weight, kidney atrophy, hyperphosphatemia, and increased

138 se resulting from cleavage of high-molecular-weight kininogen.

139 h of which occurred prior to changes in body weight, lending support to a causal relationship between

140 To determine if children born with birth weight less than 1,251 g who were treated with neonatal

141 A propensity score-weighted logistic regression model was used to adjust fo

142 strongest among obese women with intentional weight loss (HR, 0.44; 95% CI, 0.25 to 0.78).

143 Child weight loss after 6 months was -0.25 BMI z scores in bot

144 Esophagectomy is associated with significant weight loss and catabolism, and negatively impacts quali

145 umber of responders at 24 h, despite greater weight loss and fluid loss.

146 ammatory colon cancer, augmented DSS-induced weight loss and increased tumor multiplicity, size, and

147 in Rag1(-/-) mice, the mice showed dramatic weight loss and ZIKV infection in the brain and testes.

148 oriasis and obesity are strongly linked, and weight loss appears to improve psoriasis symptoms and se

149 nd chronic stress and were protected against weight loss associated with chronic stress.

150 Weight loss combined with sarcopenia presented the great

151 ted the first randomized trial of behavioral weight loss for HIV-infected patients (n = 40).

152 le examines the effects of Moving Forward, a weight loss intervention for African American breast can

153 Weight loss is also associated with a changing dietary m

154 th follow-up with a mean difference in child weight loss of 0.001 (95% CI, -0.06 to 0.06).

155 e intervention trial and achieved an average weight loss of 10.5 kg (10% of initial body weight).

156 Thermogravimetric analysis showed a weight loss of 85.81+/-0.52% and a decomposition tempera

157 radiation of the intestine did not cause any weight loss or lethality.

158 st-guided (n = 125) or self-guided (n = 121) weight loss program supporting behavioral changes to pro

159 tudy to consider oxytocin as a neurohormonal weight loss treatment.

160 These recommendations can include weight loss, adequate hydration, avoidance of excessive

161 Survival, weight loss, and viral titers were assessed over a 14-da

162 dney), resulted in rapid lethality marked by weight loss, changes in nutritional as well as blood par

163 The secondary end points included short-term weight loss, serum obesity-related hormone levels, hunge

164 ojections for cisplatin-induced anorexia and weight loss.

165 mediates cisplatin-induced anorexia and body weight loss.

166 upporting behavioral changes to promote a 5% weight loss.

167 e studied the effects of a diet and exercise weight-loss intervention on skeletal muscle (SM) mass an

168 Adding exercise to a short-term weight-loss program should be considered as a useful str

169 With its light weight, low cost and high efficiency even at low operati

170 iteria were gestational age <32 weeks, birth weight <1000 g, known immunodeficiency or no Danish-spea

171 bservational study of preterm infants (birth weight <1500 g and/or gestational age <32 weeks) was car

172 able histology Wilms tumors with nephrectomy weight <550g and age at diagnosis <2 years) results in s

173 -birth-weight babies having a very low birth weight (<1,500 g) in the more recent birth cohort.

174 ndependently increases the risk of low birth weight (<2,500 g) and preterm birth (<37 weeks' gestatio

175 enmark (Statens Serum Institut) given to low-weight (LW) neonates (<2500 g at inclusion) to reduce in

176 DN) of the pediatric brain on nonenhanced T1-weighted magnetic resonance (MR) images.

177 of the dentate nucleus (DN) on unenhanced T1-weighted magnetic resonance (MR) images.

178 arse profile, dinucleotide profile, position weight matrix profile, Markov motif profile and polypyri

179 Prominent magazines have stated that weight may be adversely affected by antibiotics that des

180 tions of the 21 PCB congeners had a national weighted mean of 32.7 mug/kg and a maximum concentration

181 wo or more survey datapoints, the population-weighted median annual rate of change of catastrophic pa

182 merization of water-insoluble, low-molecular-weight monomers that show a large change in density upon

183 ailable motion signals uniformly, but rather weights motion preferentially in a narrow band at approx

184 modalities such as T1-weighted and diffusion-weighted MR imaging could reveal imaging biomarkers asso

185 To assess the role of diffusion-weighted MR imaging in differentiation between Graves' d

186 ulative number of new lesions enhanced on T1-weighted MRI ["enhancing lesions"], and cumulative combi

187 Individual sites analysed structural T1-weighted MRI brain scans with harmonised protocols of in

188 metry platform that takes in preprocessed T1-weighted MRI data and outputs volume, surface, and tabul

189 unique lesions [new enhancing lesions on T1-weighted MRI plus new and newly enlarged lesions on T2-w

190 and 24 months (change in lesion volume on T2-weighted MRI, cumulative number of new lesions enhanced

191 Using gadolinium-enhanced T1-weighted MRI, we determined that vascular permeability i

192 RI plus new and newly enlarged lesions on T2-weighted MRI]).

193 Weighted multivariable regression was used to examine tr

194 A weighted, multivariable, extended Cox regression was con

195 er proportion of hydrolysates with molecular weight (MW) <2kDa (79.8-82.7%).

196 binding sites is analyzed by constructing a weighted network of binding sites based on their structu

197 in the 28(th) week of gestation, with birth weight of 950 grams, who was born in an ambulance by spo

198 ECF based cells that will increase the total weight of devices.

199 (p < 0.001) than controls, and the mean body weight of gene-edited fry increased by 29.7%.

200 The molecular weight of the complex was calculated from small-angle X-

201 chromatography analyses, the peak molecular weight of the PAM was reduced by 2 orders of magnitude,

202 l logistic regression analysis to assess the weighting of histologic features with the diagnosis.

203 ion of aberrant pain processing as disturbed weighting of predictions and prediction errors.

204 hexa-, and hepta-saccharides with molecular weights of 689, 851, 1013 and 1151Da, respectively.

205 The only parameters in the approach are the weights of the neural network, which are automatically o

206 Such sensory weighting often leads to a dominance of a certain sense

207 ular weight species, and these low molecular weight oligomers are significantly more bioactive on syn

208 This results in soluble low-molecular-weight oligomers that can act as a therapeutic agent in

209 h result from the formation of low molecular weight oligomers, high molecular weight oligomers, proto

210 w molecular weight oligomers, high molecular weight oligomers, protofibrils, and fibrils.

211 etation under specific assumptions, of birth weight on educational attainment using instrumental vari

212 a dose of 20 mg or 40 mg, according to body weight) or placebo, administered subcutaneously every 2

213 regression adjustment for concurrent height, weight, or BMI.

214 en based on analyses "adjusting" for height, weight, or body mass index (BMI; weight (kg)/height (m)2

215 picin (600 mg or 900 mg per day according to weight, oral or intravenous) versus identical placebo, t

216 The weighted overall effects indicated that the magnesium-su

217 ore was associated with a 0.13-kg lower body weight (P < 0.001) and a 0.26-cm(3) lower AFA (P < 0.01)

218 marily the accessibility of higher molecular weight PAHs (log Kow > 6) was affected.

219 2 weeks follow-up were assessed in 28 excess-weight participants.

220 ith pressure is attributed to the squeeze of weighted phase-spaces phonons get emitted or absorbed.

221 Between 1980 and 2010, population-weighted PM2.5 exposures fell by about half, and the est

222 cromolecular populations; the high molecular weight population showed a clear trend of reduced molecu

223 rom 2578+/-86mg/kg to 5063+/-230mg/kg of dry weight potato flesh.

224 idal volume from 6 to 8 mL/kg predicted body weight predicted fluid responsiveness with areas under t

225 ta suggests that interarterial ALCA is rare (weighted prevalence = 0.03%; 95% confidence interval [CI

226 to 0.04%) compared with interarterial ARCA (weighted prevalence = 0.23%; 95% CI: 0.17% to 0.31%).

227 elated injury was reported by 1430 groomers (weighted prevalence, 25.6%), with more women sustaining

228 These findings suggest that weight problems in adulthood may be rooted partially in

229 usion chromatography, and one high molecular weight protein was detected relative to the hemoglobin (

230 , phosphaturia, aminoaciduria, low molecular weight proteinuria, and albuminuria.

231 w of the current literature on low-molecular-weight PSMA ligands for both PET imaging and therapeutic

232 urses were similar in both groups, and birth weights ranged from 580 to 1495 g in the lower-protein g

233 The decrease of the T1/T2-weighted ratio in the posterior cingulate was related to

234 e displayed reduced LV and lung mass to body weight ratios and improved ejection fraction at d5 post-

235 months, either in the commercial population (weighted RD per 1000, -0.08; 95% CI, -0.51 to 0.36) or t

236 36) or the Medicare Supplemental population (weighted RD per 1000, -0.45; 95% CI, -1.53 to 0.58).

237 trols, Ati-CB1-KO mice showed decreased body weight, reduced total adiposity, improved insulin sensit

238 to the normoglycemic range with significant weight reduction in a high-fat diet (HFD) induced diabet

239 However, the recent finding of sustained weight reduction in response to systemic administration

240 ot have a measurable impact on the molecular weight reduction of waxy flour.

241 nea reduction, despite significantly greater weight reduction with tolvaptan (-2.4 +/- 2.1 kg vs. -0.

242 of weight stabilization (WS) and the risk of weight regain.In this randomized controlled trial, 61 he

243 nes are associated with an increased risk of weight regain.We investigated the relation between the e

244 s, strategic longitudinal observation during weight restoration, and large-scale data pooling.

245 diplopia presentations were estimated using weighted sample data.

246 We have shown that with the appropriate weighting scheme, we can remove the length effects on th

247 ollection contributed to at least 70% of the weighted score and predicted a 254-1,333% increase in ME

248 al interdependencies and utilizing ranked or weighted sequences increasingly available from high-thro

249 statistically significant dose-dependent T1-weighted signal enhancement was observed in the DN after

250 Prevalence of preterm birth, low birth weight, small-for-gestational-age births, cesarean deliv

251 nt positive associations between BPA and fat weight [SMD=0.67 (95% CI: 0.53, 0.81)], triglycerides [S

252 ced light absorption, while larger-molecular-weight species may represent recalcitrant brown carbon.

253 HMW oAbeta can dissociate into low molecular weight species, and these low molecular weight oligomers

254 They were then studied during weight stability while consuming 3 test diets, each for

255 ssion of ECM genes during WL and a period of weight stabilization (WS) and the risk of weight regain.

256 adverse pregnancy outcomes such as low birth weight, stillbirth, and prematurity.

257 rawn from the UK Biobank to identify healthy-weight-sustaining density environments.

258 ion for age, sex, birth weight, height, body weight, Tanner stage of pubertal development, axial leng

259 ive intermediates, often of higher molecular weight than the Amadori rearrangement product, contribut

260 The vapour pressure, the molecular weight, the Odor Activity Value (OAV) and the number of

261 An ideal observer will give equivalent weight to sources of information that are equally reliab

262 itiated treatment and time to treatment were weighted to account for the sampling design.

263 ary 1, 1999, to December 31, 2015, which are weighted to be representative of each state that has par

264 Results were weighted to produce US population estimates.

265 weighted Cox regression models using Barlow weights to account for the case-cohort design.

266 with allometries of kidney, spleen and liver weights to body weight, 36 of which were imprinted with

267 stigated how preconceptional and gestational weight trajectories (summarized by individual-level trai

268 t-class analysis, the highest-order maternal weight trajectory group consisted almost entirely of wom

269 maps (98%, 95 of 97 patients) than on FS PD-weighted TSE images (86%, 84 of 97 patients) (P < .001).

270 single-plane (axial) structural imaging (T2-weighted turbo spin-echo and diffusion-weighted imaging)

271 using a 3-T MR imaging system, intermediate-weighted turbo spin-echo pulse sequences, and MR-conditi

272 The unweighted and weighted UniFrac distances also revealed considerable se

273 99 % tail-to-head content and high molecular weight (up to 92.5 kg mol(-1) ).

274 ayers of the network can coordinate synaptic weight updates.

275 omes were compared using point estimates for weighted values of median overall survival, progression-

276 We used survey design and weighting variables to produce national estimates of ann

277 The prototype with reduced package weight/volume provides an impressive energy density of 2

278 P<0.0001) and accumulation of low-molecular-weight vWF multimers (+40+/-5%, P<0.0001) and vWF degrad

279 ed significant degradation of high-molecular-weight vWF multimers (-9+/-1%, P<0.0001) and accumulatio

280 The mean +/- SD birth weight was 3160 +/- 770 g in the enteral tube feeding gr

281 Birth weight was also unrelated to academic performance in ado

282 total body clearance normalized by dose and weight was lower in the Eld group compared with the Ctrl

283 ranging from 0.1 to 10(5) parts per million (weight/weight), worked equally well on different platfor

284 Total extracted lipid values on roe weight were 5.8-6.3%.

285 a significant negative association with body weight were estimated [MD=-0.22 (95% CI: -0.37, -0.06)].

286 The resulting feature weights were used to establish 3 predictive models per b

287 (GSPC), and slaughtered at 3 target carcass weights, were determined.

288 Digestion of higher molecular weight whey proteins increased with decreased pH and hig

289 was associated with smaller relative spleen weight, which is a documented consequence of chronic str

290 on showed a clear trend of reduced molecular weight with increasing extraction temperature.

291 utcomes from RBC transfusion that need to be weighted with its benefits in selected patients.

292 lymerization of ethylene to higher molecular weights with reduced branching due to significant reduct

293 e and are driven largely by height and birth weight, without any comparable influence of BMI or BSA.

294 issible level in this matrix ([Hg]=1mg/kgwet weight,ww).

295 on (zwt-3 mo), weight z score at conception, weight z score at 3 mo postconception, weight z score at

296 ry traits were expressed as weight z scores [weight z score at 3 mo preconception (zwt-3 mo), weight

297 tion, weight z score at 3 mo postconception, weight z score at 7 mo postconception (zwt+7 mo), and co

298 ht z score at 3 mo preconception (zwt-3 mo), weight z score at conception, weight z score at 3 mo pos

299 Summary traits were expressed as weight z scores [weight z score at 3 mo preconception (z

300 onsumed OI had significant decreases in body weight z-score (decrease of 3.1%), percent body fat (dec